Inactive Instrument

Shengtai Pharmaceutical, Inc. Stock Other OTC

Equities

SGTI

US8232142005

Pharmaceuticals

Sales 2011 172M Sales 2012 179M Capitalization 14.86M
Net income 2011 7M Net income 2012 1M EV / Sales 2011 0.4 x
Net Debt 2011 55.79M Net Debt 2012 86.75M EV / Sales 2012 0.57 x
P/E ratio 2011
1.63 x
P/E ratio 2012
14.1 x
Employees -
Yield 2011 *
-
Yield 2012
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chairman 65 -
Director/Board Member 54 06-03-31
Members of the board TitleAgeSince
Chairman 65 -
Director/Board Member 54 06-03-31
Director/Board Member - -
More insiders
Shengtai Pharmaceutical, Inc. (Shengtai), through its wholly owned subsidiary, Weifang Shengtai Pharmaceutical Inc., is a producer of pharmaceutical-grade glucose in China. The Company's products include pharmaceutical-grade glucose or dextrose, used for medical purposes, as well as other glucose and cornstarch products used for the food and beverage industry, and for industrial productions in China. The Company's glucose series include dextrose monohydrate (DMH), dextrose anhydrous, oral glucose dextrin and rough glucose for other processing purposes. Its starch series include pharmaceutical starch and edible corn starch. The Company's customers include healthcare institutions, food and beverage companies, pharmaceutical companies, medical supply exporters and medical supply. The Company also exports its products to approximately 70 different countries overseas, such as Japan, Singapore, Korea, Australia, Russia and India.
More about the company